• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Adherence to and uptake of clinical practice guidelines: lessons learned from a clinical practice guideline on chemotherapy concomitant with radiotherapy in head-and-neck cancer.临床实践指南的依从性与采纳情况:从一项关于头颈部癌放化疗联合治疗的临床实践指南中吸取的经验教训。
Curr Oncol. 2015 Apr;22(2):e61-8. doi: 10.3747/co.22.2235.
2
Did the addition of concomitant chemotherapy to radiotherapy improve outcomes in hypopharyngeal cancer? A population-based study.同步放化疗能否改善下咽癌的治疗效果?一项基于人群的研究。
Curr Oncol. 2016 Aug;23(4):266-72. doi: 10.3747/co.23.3085. Epub 2016 Aug 12.
3
Impact of the addition of chemotherapy to radiotherapy for oropharyngeal cancer in 2003-2004: Population-based study from the Province of Ontario, Canada.2003 - 2004年化疗联合放疗对口咽癌的影响:来自加拿大安大略省的基于人群的研究。
Head Neck. 2015 Oct;37(10):1461-9. doi: 10.1002/hed.23777. Epub 2014 Jul 21.
4
Can surveying practitioners about their practices help identify priority clinical practice guideline topics?向从业者调查他们的实践情况有助于确定临床实践指南的优先主题吗?
BMC Health Serv Res. 2003 Dec 19;3(1):23. doi: 10.1186/1472-6963-3-23.
5
Impact of concomitant chemotherapy on outcomes of radiation therapy for head-and-neck cancer: a population-based study.同期化疗对头颈部癌症放射治疗结果的影响:一项基于人群的研究。
Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):115-21. doi: 10.1016/j.ijrobp.2013.09.052.
6
Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.直肠癌 II 期或 III 期的术前或术后治疗:更新的实践指南。
Clin Oncol (R Coll Radiol). 2010 May;22(4):265-71. doi: 10.1016/j.clon.2010.03.002.
7
Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.局部晚期非小细胞肺癌的根治性和辅助放疗:美国临床肿瘤学会临床实践指南对美国放射肿瘤学会循证临床实践指南的认可。
J Clin Oncol. 2015 Jun 20;33(18):2100-5. doi: 10.1200/JCO.2014.59.2360. Epub 2015 May 5.
8
Is neck dissection necessary after induction plus concurrent chemoradiotherapy in complete responder head and neck cancer patients with pretherapy advanced nodal disease?诱导化疗联合同期放化疗后,治疗前存在高级别淋巴结转移的完全缓解的头颈部鳞癌患者是否需要行颈清扫术?
Ann Surg Oncol. 2013 Jan;20(1):250-6. doi: 10.1245/s10434-012-2520-2. Epub 2012 Jul 27.
9
Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy.根治性子宫切除术后中危宫颈癌患者接受拓扑替康和顺铂放疗或放化疗的随机 III 期试验。
BMC Cancer. 2015 May 4;15:353. doi: 10.1186/s12885-015-1355-1.
10
Functional outcomes of chemoradiation in patients with head and neck cancer.头颈部癌症患者放化疗的功能预后。
Otolaryngol Head Neck Surg. 2013 Jan;148(1):64-8. doi: 10.1177/0194599812459325. Epub 2012 Sep 5.

引用本文的文献

1
Human Papillomavirus-Related Non-Metastatic Oropharyngeal Carcinoma: Current Local Treatment Options and Future Perspectives.人乳头瘤病毒相关的非转移性口咽癌:当前局部治疗选择及未来展望
Cancers (Basel). 2022 Nov 1;14(21):5385. doi: 10.3390/cancers14215385.
2
Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy.老年患者头颈部鳞状细胞癌:放疗与化疗的作用
Cancers (Basel). 2022 Jan 18;14(3):472. doi: 10.3390/cancers14030472.
3
Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.肿瘤内异质性可为头颈部鳞状细胞癌患者提供术后辅助治疗的选择和类型。
Cancer. 2020 Jan 1;126(9):1895-1904. doi: 10.1002/cncr.32742. Epub 2020 Feb 21.
4
Customized registry tool for tracking adherence to clinical guidelines for head and neck cancers: protocol for a pilot study.用于跟踪头颈癌临床指南依从性的定制登记工具:一项试点研究方案
Pilot Feasibility Stud. 2020 Feb 7;6:16. doi: 10.1186/s40814-020-0552-0. eCollection 2020.
5
Factors associated with receipt of symptom screening in the year after cancer diagnosis in a universal health care system: a retrospective cohort study.在全民医疗保健系统中,癌症诊断后一年内接受症状筛查的相关因素:一项回顾性队列研究。
Curr Oncol. 2019 Feb;26(1):e8-e16. doi: 10.3747/co.26.4160. Epub 2019 Feb 1.
6
The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting.在现实环境中,对于低风险人乳头瘤病毒(HPV)相关的口咽癌,放疗联合化疗并未降低远处转移率。
Head Neck. 2019 Jul;41(7):2271-2276. doi: 10.1002/hed.25679. Epub 2019 Feb 4.
7
Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study.在传统放疗基础上加用同步化疗是否能提高人乳头瘤病毒(HPV)阳性和阴性口咽癌患者的生存率?一项基于人群的研究。
Br J Cancer. 2017 Oct 10;117(8):1105-1112. doi: 10.1038/bjc.2017.275. Epub 2017 Aug 22.
8
Hydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.羟氯喹在免疫介导性疾病中的剂量:对患者安全的影响。
Rheumatol Int. 2017 Oct;37(10):1611-1618. doi: 10.1007/s00296-017-3782-6. Epub 2017 Jul 26.
9
Feedback preferences of patients, professionals and health insurers in integrated head and neck cancer care.头颈部癌症综合治疗中患者、专业人员和健康保险公司的反馈偏好。
Health Expect. 2017 Dec;20(6):1275-1288. doi: 10.1111/hex.12567. Epub 2017 Jun 15.
10
Implementation of study results in guidelines and adherence to guidelines in clinical practice.研究结果在指南中的实施以及临床实践中对指南的遵循。
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2016 Dec 15;15:Doc01. doi: 10.3205/cto000128. eCollection 2016.

本文引用的文献

1
Impact of the addition of chemotherapy to radiotherapy for oropharyngeal cancer in 2003-2004: Population-based study from the Province of Ontario, Canada.2003 - 2004年化疗联合放疗对口咽癌的影响:来自加拿大安大略省的基于人群的研究。
Head Neck. 2015 Oct;37(10):1461-9. doi: 10.1002/hed.23777. Epub 2014 Jul 21.
2
Evaluation of treatment benefit: randomized controlled trials and population-based observational research.治疗益处评估:随机对照试验和基于人群的观察性研究。
J Clin Oncol. 2013 Sep 10;31(26):3298-9. doi: 10.1200/JCO.2013.51.5023. Epub 2013 Aug 12.
3
Evaluation of treatment benefit in Journal of Clinical Oncology.《临床肿瘤学杂志》中治疗益处的评估。
J Clin Oncol. 2013 Mar 20;31(9):1123-4. doi: 10.1200/JCO.2012.47.6952. Epub 2013 Jan 28.
4
Prereferral head and neck cancer treatment: compliance with national comprehensive cancer network treatment guidelines.转诊前头颈癌治疗:对国家综合癌症网络治疗指南的依从性
Arch Otolaryngol Head Neck Surg. 2010 Dec;136(12):1205-11. doi: 10.1001/archoto.2010.206.
5
Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?甲状腺髓样癌:美国的实践模式与美国甲状腺协会指南是否存在差异?
Ann Surg Oncol. 2010 Jun;17(6):1490-8. doi: 10.1245/s10434-010-1017-0. Epub 2010 Mar 12.
6
Knowledge creation: synthesis, tools and products.知识创造:综合、工具与产品。
CMAJ. 2010 Feb 9;182(2):E68-72. doi: 10.1503/cmaj.081230. Epub 2009 Nov 2.
7
Effects of evidence-based clinical practice guidelines on quality of care: a systematic review.循证临床实践指南对医疗质量的影响:一项系统评价
Qual Saf Health Care. 2009 Oct;18(5):385-92. doi: 10.1136/qshc.2008.028043.
8
Radiotherapy or surgery for head and neck squamous cell cancer: establishing the baseline for hypopharyngeal carcinoma?头颈部鳞状细胞癌的放疗或手术:为喉咽癌建立基线?
Cancer. 2009 Dec 15;115(24):5711-22. doi: 10.1002/cncr.24635.
9
Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review.影响医疗保健专业人员临床指南实施的因素:一项系统性的元综述。
BMC Med Inform Decis Mak. 2008 Sep 12;8:38. doi: 10.1186/1472-6947-8-38.
10
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.头颈部癌的超分割或加速放疗:一项荟萃分析。
Lancet. 2006 Sep 2;368(9538):843-54. doi: 10.1016/S0140-6736(06)69121-6.

临床实践指南的依从性与采纳情况:从一项关于头颈部癌放化疗联合治疗的临床实践指南中吸取的经验教训。

Adherence to and uptake of clinical practice guidelines: lessons learned from a clinical practice guideline on chemotherapy concomitant with radiotherapy in head-and-neck cancer.

作者信息

Hall S F, Irish J C, Gregg R W, Groome P A, Rohland S

机构信息

Department of Otolaryngology, Queen's University, Kingston, ON. ; Division of Cancer Care and Epidemiology, Queen's University, Kingston, ON.

Department of Otolaryngology, Queen's University, Kingston, ON. ; Department of Surgical Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON.

出版信息

Curr Oncol. 2015 Apr;22(2):e61-8. doi: 10.3747/co.22.2235.

DOI:10.3747/co.22.2235
PMID:25908922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4399625/
Abstract

BACKGROUND

Clinical practice guidelines (cpgs) are systematically developed statements designed to assist practitioners and patients in making decisions about appropriate heath care interventions. Clinical practice guidelines are expensive and time-consuming to create. A cpg on concurrent chemotherapy with radiation therapy (ccrt) was developed in Ontario at a time when treatment approaches for head-and-neck cancer were changing significantly.

METHODS

An assessment of treatments and outcomes based on electronic and chart data obtained from a population-based study of 571 patients with oropharynx cancer treated in Ontario (2003-2004) was combined with a review of relevant knowledge transfer (publications and presentations at major meetings) to understand variation in adherence to a cpg.

RESULTS

In 9 Ontario cancer treatment centres, ccrt was used for 55% of all patients with oropharyngeal cancer; however, at the centres individually, that proportion ranged from 82% to 39%. Furthermore, there was no agreement on the chemotherapy regimen: 2-4 years later (a period during which newer regimens were emerging), only 4 of 9 centres were following the guideline for most patients. When outcomes of treated patients were compared for centres with "higher" and "lower" use of ccrt, no difference in survival was observed (p = 0.64).

CONCLUSIONS

At a time of treatment evolution, the new guideline was controversial, and there are many reasons for the mixed adherence. An estimation of adherence should be included during both development and review of guidelines.

摘要

背景

临床实践指南(CPGs)是系统制定的声明,旨在帮助从业者和患者就适当的医疗保健干预措施做出决策。制定临床实践指南成本高昂且耗时。在安大略省,当头颈癌的治疗方法正在发生重大变化时,制定了一项关于同步放化疗(CCRT)的临床实践指南。

方法

基于对安大略省571例口咽癌患者(2003 - 2004年)进行的一项基于人群的研究中获得的电子和图表数据对治疗及结果进行评估,并结合对相关知识传播情况(主要会议上的出版物和报告)的审查,以了解对临床实践指南遵循情况的差异。

结果

在安大略省的9个癌症治疗中心,55%的口咽癌患者接受了同步放化疗;然而,在各个中心,这一比例在82%至39%之间。此外,对于化疗方案也没有达成一致:2至4年后(在此期间出现了更新的方案),9个中心中只有4个中心对大多数患者遵循了该指南。当比较同步放化疗使用“较多”和“较少”的中心中接受治疗患者的结果时,未观察到生存率的差异(p = 0.64)。

结论

在治疗方法演变的时期,新指南存在争议,并且存在多种导致混合遵循情况的原因。在指南的制定和审查过程中都应纳入对遵循情况的评估。